Healthcare Global Enterprises Complete Financial Statements
12 Years of Data
2026 - 2015
In FY2026, Healthcare Global Enterprises (HCG) reported revenue ₹664 Cr, net profit ₹4 Cr and EPS ₹0.15, with a net profit margin of 0.6% and ROE of 0.3%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore HCG value investing to estimate fundamental worth using multiple valuation models.
Complete Financial Data Export
Profitability Ratios
Net Profit Margin
0.60%
2026 data
EBITDA Margin
15.81%
2026 data
Operating Margin
14.00%
2026 data
Return on Assets
0.10%
2026 data
Return on Equity
0.30%
2026 data
Balance Sheet Ratios
Current Ratio
0.76
2026 data
Equity Ratio
33.95%
2026 data
Asset Turnover
0.17
2026 data
HCG Revenue, Net Profit & EBITDA — Year-on-Year Growth
HCG YoY (Mar 2025 vs Mar 2026) — revenue +11.8%, net profit -42.9%, EBITDA -7.9%, expenses +16.5%. Review HCG P/E comparison to evaluate earnings-based valuation against sector peers.
Revenue Growth
+11.8%
Year-over-Year
Net Profit Growth
-42.9%
Year-over-Year
EBITDA Growth
-7.9%
Year-over-Year
Expense Growth
+16.5%
Year-over-Year
Assets Growth
+10.7%
Year-over-Year
Equity Growth
+34.5%
Year-over-Year
Operating Cash Flow Growth
+11.2%
Year-over-Year
Investing Cash Flow Growth
-115.9%
Year-over-Year
Financing Cash Flow Growth
+34.4%
Year-over-Year
HCG Income Statement — Revenue, EBITDA & Net Profit
Healthcare Global Enterprises revenue ₹664 Cr, EBITDA ₹105 Cr, net profit ₹4 Cr, EPS ₹0.15 (2026) — net profit margin 0.6%. For live price, earnings ratios and company overview, see Healthcare Global Enterprises screener.
Periods
₹ Crores
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Sept 2024 | Mar 2024 | Jun 2024 | Dec 2024 | Sept 2023 | Mar 2023 | Jun 2023 | Dec 2023 | Sept 2022 | Mar 2022 | Jun 2022 | Dec 2022 | Sept 2021 | Mar 2021 | Jun 2021 | Dec 2021 | Sept 2020 | Mar 2020 | Jun 2020 | Dec 2020 | Sept 2019 | Mar 2019 | Jun 2019 | Dec 2019 | Sept 2018 | Mar 2018 | Jun 2018 | Dec 2018 | Sept 2017 | Mar 2017 | Jun 2017 | Dec 2017 | Sept 2016 | Mar 2016 | Jun 2016 | Dec 2016 | Sept 2015 | Mar 2015 | Jun 2015 | Dec 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 664 | 648 | 594 | 619 | 634 | 564 | 502 | 534 | 563 | 489 | 446 | 463 | 475 | 421 | 367 | 410 | 428 | 495 | 302 | 326 | 360 | 251 | 271 | 195 | 279 | 279 | 261 | 270 | 279 | 248 | 229 | 228 | 250 | 219 | 186 | 194 | 212 | 176 | 156 | 170 | 178 | 143 | 133 | 142 | 143 |
| Expenses | 559 | 524 | 480 | 505 | 536 | 451 | 403 | 435 | 470 | 402 | 365 | 386 | 391 | 345 | 302 | 336 | 349 | 292 | 343 | 272 | 342 | 218 | 236 | 176 | 245 | 238 | 231 | 228 | 234 | 213 | 191 | 198 | 222 | 180 | 153 | 162 | 180 | 149 | 131 | 144 | 150 | 127 | 115 | 123 | 125 |
| EBITDA | 105 | 125 | 114 | 114 | 98 | 112 | 100 | 99 | 93 | 87 | 80 | 76 | 84 | 76 | 65 | 74 | 78 | 202 | -41 | 55 | 18 | 33 | 35 | 19 | 34 | 42 | 30 | 43 | 45 | 34 | 38 | 30 | 28 | 39 | 34 | 32 | 32 | 28 | 25 | 26 | 28 | 17 | 19 | 19 | 18 |
| Operating Profit Margin % | 14.00% | 19.00% | 18.00% | 17.00% | 15.00% | 18.00% | 18.00% | 17.00% | 16.00% | 17.00% | 17.00% | 16.00% | 17.00% | 18.00% | 17.00% | 18.00% | 18.00% | 17.00% | -16.00% | 16.00% | 4.00% | 12.00% | 12.00% | 8.00% | 10.00% | 14.00% | 10.00% | 15.00% | 15.00% | 13.00% | 14.00% | 13.00% | 11.00% | 15.00% | 16.00% | 15.00% | 13.00% | 15.00% | 15.00% | 14.00% | 15.00% | 11.00% | 13.00% | 13.00% | 12.00% |
| Depreciation | 63 | 63 | 58 | 58 | 61 | 50 | 46 | 47 | 57 | 43 | 42 | 41 | 44 | 41 | 41 | 40 | 41 | 38 | 38 | 38 | 41 | 40 | 42 | 39 | 42 | 35 | 23 | 34 | 38 | 21 | 21 | 20 | 22 | 17 | 15 | 15 | 18 | 14 | 12 | 13 | 15 | 11 | 10 | 11 | 11 |
| Interest | 43 | 44 | 44 | 46 | 45 | 36 | 27 | 34 | 41 | 27 | 26 | 26 | 30 | 26 | 24 | 25 | 27 | 23 | 26 | 26 | 24 | 27 | 36 | 37 | 29 | 35 | 16 | 31 | 36 | 24 | 15 | 18 | 13 | 10 | 7 | 7 | 10 | 6 | 11 | 5 | 5 | 9 | 9 | 9 | 10 |
| Profit Before Tax | 1 | 20 | 14 | 12 | -6 | 28 | 28 | 19 | -3 | 18 | 13 | 11 | 11 | 10 | 1 | 10 | 11 | 142 | -104 | -9 | -46 | -32 | -42 | -57 | -35 | -27 | -8 | -23 | -28 | -10 | 2 | -8 | -7 | 12 | 12 | 10 | 4 | 8 | 2 | 8 | 8 | -1 | 0 | 0 | -1 |
| Tax | -3 | -1 | 7 | 6 | 2 | 7 | 5 | 5 | -11 | 7 | 8 | 7 | 8 | 5 | -1 | 8 | 7 | 43 | 9 | 4 | 4 | -5 | 9 | -11 | -1 | -2 | 3 | -2 | 1 | -3 | 2 | -1 | -1 | 2 | 4 | 4 | 2 | 3 | -2 | 3 | 3 | -1 | 0 | 0 | 1 |
| Net Profit | 4 | 21 | 7 | 6 | -8 | 21 | 24 | 14 | 8 | 11 | 6 | 4 | 3 | 5 | 2 | 3 | 4 | 99 | -114 | -13 | -50 | -27 | -50 | -46 | -35 | -25 | -11 | -21 | -29 | -8 | 0 | -6 | -6 | 10 | 8 | 6 | 1 | 5 | 4 | 5 | 5 | -1 | 0 | 1 | -2 |
| Earnings Per Share (₹) | 0.15 | 1.16 | 0.53 | 0.34 | -0.68 | 1.29 | 1.53 | 0.87 | 0.50 | 0.97 | 0.60 | 0.55 | 0.41 | 0.53 | 0.43 | 0.44 | 0.54 | 8.22 | -8.14 | -0.76 | -3.55 | -1.94 | -4.91 | -4.48 | -2.33 | -2.51 | -0.99 | -2.05 | -2.57 | -0.74 | 0.30 | -0.39 | -0.71 | 1.17 | 0.90 | 0.55 | 0.37 | 0.58 | 0.44 | 0.59 | 0.63 | -0.23 | -0.04 | -0.07 | -0.30 |
HCG Balance Sheet — Assets, Liabilities & Shareholders' Equity
HCG total assets ₹3,923 Cr, total equity ₹1,332 Cr, total liabilities ₹ Cr (2026) — ROE 0.3%.
Years
Annual Data
₹ Crores
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 3,923 | 3,543 | 2,708 | 2,316 | 2,220 | 2,036 | 2,253 | 1,654 | 1,444 | 1,226 | 1,034 | 776 |
| Current Assets | 1,135 | 844 | 680 | 580 | 502 | 435 | 304 | 273 | 220 | 244 | 201 | 122 |
| Fixed Assets | 2,093 | 2,442 | 1,758 | 1,553 | 1,547 | 1,382 | 1,646 | 970 | 828 | 685 | 568 | 529 |
| Capital Work in Progress | 19 | 25 | 83 | 18 | 22 | 30 | 46 | 153 | 174 | 148 | 155 | 42 |
| Investments | 60 | 11 | 10 | 10 | 9 | 26 | 34 | 49 | 53 | 11 | 60 | 0 |
| Other Assets | 0 | 1,065 | 856 | 735 | 642 | 597 | 527 | 482 | 389 | 382 | 252 | 205 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 1,495 | 1,507 | 1,099 | 876 | 866 | 856 | 1,258 | 584 | 506 | 371 | 270 | 284 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 1,332 | 990 | 865 | 869 | 884 | 714 | 420 | 522 | 579 | 490 | 569 | 305 |
| Share Capital | 149 | 139 | 139 | 139 | 139 | 125 | 89 | 88 | 87 | 86 | 85 | 70 |
| Reserves & Surplus | 1,183 | 783 | 687 | 721 | 731 | 528 | 293 | 389 | 398 | 347 | 451 | 209 |
HCG Cash Flow Statement — Operating, Investing & Financing
Healthcare Global Enterprises operating cash flow ₹317 Cr, investing ₹-488 Cr, financing ₹-42 Cr, net cash flow ₹-213 Cr (2025).
Periods
₹ Crores
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 317 | 285 | 252 | 220 | 121 | 130 | 99 | 98 | 91 | 73 | 60 |
| Investing Activities | -488 | -226 | -133 | 125 | -171 | -101 | -238 | -283 | -210 | -204 | -79 |
| Financing Activities | -42 | -64 | -140 | -155 | 112 | -58 | 84 | 161 | 89 | 216 | 22 |
| Net Cash Flow | -213 | -5 | -22 | 190 | 62 | -30 | -56 | -24 | -29 | 85 | 3 |